PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8234726

Temporal lobes: surface MR coil phased-array imaging.

C E Hayes·J S Tsuruda·C M Mathis
View original source ↗Export metadata ↓

Abstract

The authors describe a four-coil surface phased-array coil for magnetic resonance (MR) imaging of the temporal lobes. On the basis of measurements in a phantom, the signal-to-noise ratio of the array is 1.67 times or more better than that obtained with a standard quadrature head coil in the region of the hippocampi. The higher sensitivity of this phased array permits use of imaging pulse sequences for which the head coil is inadequate.

Explore related subjects

EpilepsyHippocampusHumansMagnetic Resonance ImagingModels, StructuralSclerosisSensitivity and SpecificityTemporal LobeJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C E Hayes, J S Tsuruda, C M Mathis. 1993. Temporal lobes: surface MR coil phased-array imaging.. https://doi.org/10.1148/radiology.189.3.8234726

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Long-term seizure outcomes and factors associated with response to adjunctive everolimus in TSC-associated epilepsy.

BACKGROUND: Everolimus, a mechanistic target of rapamycin (mTOR) inhibitor, is increasingly used in tuberous sclerosis complex (TSC)-associated epilepsy; however, long-term real-world outcomes and factors associated with favorable response remain unclear. This study aimed to evaluate the long-term seizure outcomes of adjunctive everolimus and explore clinical factors associated with treatment response. METHODS: We retrospectively recruited 21 patients with active TSC-associated epilepsy receiving adjunctive everolimus and assessed seizure outcomes during follow-up. Clinical characteristics were compared between responders and non-responders at 1 year after treatment initiation. RESULTS: Over a median treatment duration of 72 months, responder rates ranged from 53.8% to 64.7%, and seizure-free rates ranged from 33.3% to 41.2%. Responders had fewer involved organ systems at baseline (median 3 vs. 4, p = 0.020) and lower anti-seizure medication burden (median 2 vs. 4, p = 0.045). Younger age at treatment initiation showed a trend toward improved response. CONCLUSION: Adjunctive everolimus was associated with sustained long-term seizure reduction in this real-world cohort. In exploratory analyses, fewer involved organ systems and fewer baseline ASMs were associated with favorable treatment response. These findings require validation in larger prospective cohorts.

Epilepsy↗
PubMed1997

Migraine and epilepsy.

The epidemiology of the association between migraine and epilepsy is reviewed. Migraine-related epilepsy is categorized using defined diagnostic criteria. Migraine-induced epilepsy is only one of several migraine-related epileptic syndromes.

Epilepsy↗